NCT06263998View on ClinicalTrials.gov

Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

PHASE1RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

November 28, 2025

Study Completion Date

January 30, 2026

Conditions

Xerophthalmia

Interventions

DRUG

NCP112

NCP112 topical ophthalmic solution

DRUG

NCP112 Placebo

Placebo comparator

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY